Gefitinib-resistance is related to BIM expression in non-small cell lung cancer cell lines

Gespeichert in:
Bibliographische Detailangaben
Weitere Verfasser: Li, Heyan (BerichterstatterIn) , Schmid-Bindert, Gerald (BerichterstatterIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2013
In: Cancer biotherapy & radiopharmaceuticals
Year: 2013, Jahrgang: 28, Heft: 2, Pages: 115-123
ISSN:1084-9785
Online-Zugang: Volltext
Verfasserangaben:Li, Heyan ... Schmid-Bindert, Gerald

MARC

LEADER 00000caa a22000002c 4500
001 1631672029
003 DE-627
005 20220815175534.0
007 tu
008 130416s2013 xx ||||| 00| ||eng c
035 |a (DE-627)1631672029 
035 |a (DE-576)381204634 
035 |a (DE-599)BSZ381204634 
035 |a (OCoLC)1341053090 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
084 |a 33  |2 sdnb 
245 0 0 |a Gefitinib-resistance is related to BIM expression in non-small cell lung cancer cell lines  |c Li, Heyan ... Schmid-Bindert, Gerald 
264 1 |c 2013 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
700 1 |a Li, Heyan  |4 oth 
700 1 |a Schmid-Bindert, Gerald  |d 1969-  |0 (DE-588)121300129  |0 (DE-627)081214170  |0 (DE-576)292636024  |4 oth 
773 0 8 |i In  |t Cancer biotherapy & radiopharmaceuticals  |d Larchmont, NY : Liebert, 1996  |g 28(2013), 2, Seite 115-123  |w (DE-627)198681895  |w (DE-600)1315649-4  |w (DE-576)100517153  |x 1084-9785  |7 nnas  |a Gefitinib-resistance is related to BIM expression in non-small cell lung cancer cell lines 
773 1 8 |g volume:28  |g year:2013  |g number:2  |g pages:115-123  |g extent:9  |a Gefitinib-resistance is related to BIM expression in non-small cell lung cancer cell lines 
951 |a AR 
992 |a 20130416 
993 |a Article 
994 |a 2013 
998 |g 121300129  |a Schmid-Bindert, Gerald  |m 121300129:Schmid-Bindert, Gerald  |d 60000  |d 61800  |e 60000PS121300129  |e 61800PS121300129  |k 0/60000/  |k 1/60000/61800/  |p 7  |y j 
999 |a KXP-PPN1631672029  |e 3282775741 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"part":{"year":"2013","pages":"115-123","volume":"28","text":"28(2013), 2, Seite 115-123","extent":"9","issue":"2"},"type":{"bibl":"periodical"},"pubHistory":["11.1996 -"],"id":{"eki":["198681895"],"zdb":["1315649-4"],"issn":["1084-9785"]},"language":["eng"],"title":[{"title":"Cancer biotherapy & radiopharmaceuticals","title_sort":"Cancer biotherapy & radiopharmaceuticals","subtitle":"a journal of new cancer treatment modalities"}],"titleAlt":[{"title":"Cancer biotherapy and radiopharmaceuticals"}],"recId":"198681895","disp":"Gefitinib-resistance is related to BIM expression in non-small cell lung cancer cell linesCancer biotherapy & radiopharmaceuticals","origin":[{"dateIssuedDisp":"1996-","publisher":"Liebert","publisherPlace":"Larchmont, NY","dateIssuedKey":"1996"}]}],"type":{"bibl":"article-journal"},"id":{"eki":["1631672029"]},"physDesc":[{"extent":"9 S."}],"language":["eng"],"title":[{"title_sort":"Gefitinib-resistance is related to BIM expression in non-small cell lung cancer cell lines","title":"Gefitinib-resistance is related to BIM expression in non-small cell lung cancer cell lines"}],"recId":"1631672029","origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"2013"}],"name":{"displayForm":["Li, Heyan ... Schmid-Bindert, Gerald"]},"person":[{"display":"Li, Heyan","given":"Heyan","family":"Li","role":"oth"},{"role":"oth","display":"Schmid-Bindert, Gerald","given":"Gerald","family":"Schmid-Bindert"}]} 
SRT |a GEFITINIBR2013